a randomized trial comparing the acute coronary, systemic, and environmental effects of electronic vaping cigarettes versus heat-not-burn cigarettes in smokers of combustible cigarettes undergoing invasive coronary assessment: rationale and design of the SUr-vaPeS 3 trial

Minerva Cardioangiologica

Volumn 68, Issue 6, 2020, Pages 548-555

  Zoccai, Giuseppe Biondi ^a,b   Carnevale, Roberto ^a,b   Vitali, Matteo ^c   Tritapepe, Luigi ^d   Martinelli, Ombretta ^a   Macrina, Francesco ^a   Bullen, Chris ^e   Peruzzi, Mariangela ^a,b   Cavarretta, Elena ^a,b   Marullo, Antonino G ^a   Abbate, Antonio ^f   Romagnoli, Enrico ^g   Sciarretta, Sebastiano ^a,h   Casati, Rebecca ⁱ   Visconti, Giuseppe ^j   Versaci, Francesco ⁱ   Frati, Giacomo ^a,h  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MEDITERRANEA CARDIOCENTRO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^h IRCCS NEUROMED   (Italy)

ⁱ SANTA MARIA GORETTI HOSPITAL   (Italy)

^j ASL Latina   (Italy)

more..

Author keywords

Coronary artery disease; Smoking; Vaping

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; CLOPIDOGREL; COTININE; ETHIONAMIDE; MYELOPEROXIDASE; NITRIC OXIDE; TICAGRELOR; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BURN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CIGARETTE SMOKING; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY PRESSURE; CORONARY FLOW RESERVE; CORONARY SINUS; DUAL ANTIPLATELET THERAPY; ENVIRONMENTAL FACTOR; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART ARREST; HUMAN; HYPERTENSION; INFLAMMATION; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY; RISK FACTOR; SMOKING; SPECTROSCOPY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VAPING;

EID: 85089661161     PISSN: 00264725     EISSN: 18271618     Source Type: Journal    
DOI: 10.23736/S0026-4725.20.05181-6     Document Type: Article

References (29)

1. gBd 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global Burden of disease Study 2015. lancet 2017;389:1885–906.
2. Menozzi a. an overview on STeMi. Minerva Cardioangiol 2018;66:391.
3. antonini l, Mollica C, aspromonte n, Pasceri v, auriti a, gonzini l, et al. a simple prognostic index in acute heart failure. Minerva Cardioangiol 2019;67:73–8.
4. Suissa K, larivière J, eisenberg MJ, eberg M, gore gC, grad r, et al. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular disease: a network Meta-analysis of randomized Controlled Trials. Circ Cardiovasc Qual outcomes 2017;10:e002458.
5. darville a, Hahn eJ. e-cigarettes and atherosclerotic Cardiovascular disease: What Clinicians and researchers need to Know. Curr atheroscler rep 2019;21:15.
6. Camenga DR, Tindle HA. Weighing the Risks and Benefits of electronic Cigarette Use in High-risk Populations. Med Clin north am 2018;102:765–79.
7. Bullen C, Howe C, laugesen M, Mcrobbie H, Parag v, Williman J, et al. electronic cigarettes for smoking cessation: a randomised controlled trial. lancet 2013;382:1629–37.
8. The national academies of Sciences. engineering and Medicine. Public Health Consequences of e-Cigarettes. naP; [Internet]. Available from: https://www.nap.edu/resource/249 52/012318ecigaretteConclusionsbyEvidence.pdf [cited 2020, Mar 27].
9. Biondi-Zoccai g, Peruzzi M, Frati g. e-Cigarettes, incentives, and drugs for Smoking Cessation. n engl J Med 2018;379:991–2.
10. Hajek P, Phillips-Waller a, Przulj d, Pesola F, Myers Smith K, Bisal n, et al. a randomized Trial of e-Cigarettes versus nicotine-replacement Therapy. n engl J Med 2019;380:629–37.
11. Krishnasamy vP, Hallowell Bd, Ko JY, Board a, Hartnett KP, Salvatore PP, et al.; lung injury response epidemiology/Surveillance Task Force. Update: Characteristics of a nationwide outbreak of e-cigarette, or vaping, Product Use-associated lung injury - United States, august 2019-Janu-ary 2020. MMWr Morb Mortal Wkly rep 2020;69:90–4.
12. nabavizadeh P, liu J, Havel CM, ibrahim S, derakhshandeh r, Jacob iii P, et al. vascular endothelial function is impaired by aerosol from a single iQoS HeatStick to the same extent as by cigarette smoke. Tob Control 2018;27(Suppl 1):s13–9.
13. Mastrangeli S, Carnevale r, Cavarretta e, Sciarretta S, Peruzzi M, Marullo ag, et al. Predictors of oxidative stress and vascular function in an experimental study of tobacco versus electronic cigarettes: a post hoc analysis of the SUr-vaPeS 1 Study. Tob induc dis 2018;16:18.
14. nocella C, Biondi-Zoccai g, Sciarretta S, Peruzzi M, Pagano F, loffredo l, et al. impact of Tobacco versus electronic Cigarette Smoking on Platelet Function. am J Cardiol 2018;122:1477–81.
15. Carnevale r, Sciarretta S, violi F, nocella C, loffredo l, Perri l, et al. acute impact of Tobacco vs electronic Cigarette Smoking on oxidative Stress and vascular Function. Chest 2016;150:606–12.
16. Biondi-Zoccai g, Sciarretta S, Bullen C, nocella C, violi F, loffredo l, et al. acute effects of Heat-not-Burn, electronic vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of rome-vascular assessment of Proatherosclerotic effects of Smoking (SUr - vaPeS) 2 randomized Trial. J am Heart assoc 2019;8:e010455.
17. Murphy J, gaca M, lowe F, Minet e, Breheny d, Prasad K, et al. Assessing modified risk tobacco and nicotine products: description of the scientific framework and assessment of a closed modular electronic cigarette. regul Toxicol Pharmacol 2017;90:342–57.
18. garrone P, Biondi-Zoccai g, Salvetti i, Sina n, Sheiban i, Stella Pr, et al. Quantitative coronary angiography in the current era: principles and applications. J interv Cardiol 2009;22:527–36.
19. Buffon a, Biasucci lM, liuzzo g, d’onofrio g, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. n engl J Med 2002;347:5–12.
20. ong P, athanasiadis a, Borgulya g, vokshi i, Bastiaenen r, Kubik S, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014;129:1723–30.
21. Petraco r, van de Hoef TP, nijjer S, Sen S, van lavieren Ma, Foale ra, et al. Baseline instantaneous wave-free ratio as a pressure-only estimation of underlying coronary flow reserve: results of the JUSTiFY-CFr Study (Joined Coronary Pressure and Flow analysis to determine diagnostic Characteristics of Basal and Hyperemic indices of Functional lesion Severity-Coronary Flow reserve). Circ Cardiovasc interv 2014;7:492–502.
22. Frati g, Carnevale r, nocella C, Peruzzi M, Marullo ag, de Falco e, et al. Profiling the Acute Effects of Modified risk Products: evidence from the SUr-vaPeS (Sapienza University of rome-vascular assessment of Proatherosclerotic effects of Smoking) Cluster Study. Curr atheroscler rep 2020;22:8.
23. ling PM, glantz Sa. Tobacco company strategies to identify and promote the benefits of nicotine. Tob Control 2019;28:289–96.
24. Protano C, Manigrasso M, avino P, vitali M. Secondhand smoke generated by combustion and electronic smoking devices used in real scenarios: ultrafine particle pollution and age-related dose assessment. environ int 2017;107:190–5.
25. Chu KH, Colditz JB, Primack Ba, Shensa a, allem JP, Miller e, et al. JUUL: Spreading Online and Offline. J Adolesc Health 2018;63:582–6.
26. Bhatta dn, glantz Sa. electronic Cigarette Use and Myocardial infarction among adults in the US Population assessment of Tobacco and Health. J am Heart assoc 2019;8:e012317.
27. Bhatta dn, glantz Sa. retraction to: electronic Cigarette Use and Myocardial infarction among adults in the US Population assessment of Tobacco and Health. J am Heart assoc 2020;9:e014519.
28. george J, Hussain M, vadiveloo T, ireland S, Hopkinson P, Struthers ad, et al. Cardiovascular effects of Switching From Tobacco Cigarettes to electronic Cigarettes. J am Coll Cardiol 2019;74:3112–20.
29. Hartnett KP, Kite-Powell a, Patel MT, Haag Bl, Sheppard MJ, dias TP, et al. Syndromic Surveillance for e-Cigarette, or vaping, Product Use-associated lung injury. n engl J Med 2020;382:766–72.